Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-022869
Filing Date
2023-02-16
Accepted
2023-02-16 17:05:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 tm236507-3_424b3.htm 424B3 1137618
2 GRAPHIC lg_sesenbio-4c.jpg GRAPHIC 29732
3 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 58482
4 GRAPHIC lg_mackenziepartners-bw.jpg GRAPHIC 31267
  Complete submission text file 0001104659-23-022869.txt   1303692
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267891 | Film No.: 23639275
SIC: 2834 Pharmaceutical Preparations